Patents Assigned to Resolution Pharmaceuticals
  • Metal chelators
    Patent number: 5480970
    Abstract: Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: January 2, 1996
    Assignee: Resolution Pharmaceuticals
    Inventors: Alfred Pollak, Anne Goodbody